Cite
HARVARD Citation
Ghang, B. et al. (2017). Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy. Modern rheumatology. 27 (3), pp. 405-410. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ghang, B. et al. (2017). Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy. Modern rheumatology. 27 (3), pp. 405-410. [Online].